State of Wyoming Sells 8,069 Shares of CVS Health Corporation $CVS

State of Wyoming lowered its position in CVS Health Corporation (NYSE:CVS) by 50.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,829 shares of the pharmacy operator’s stock after selling 8,069 shares during the period. State of Wyoming’s holdings in CVS Health were worth $590,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its holdings in CVS Health by 1.7% during the second quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock valued at $8,305,132,000 after buying an additional 2,063,737 shares during the last quarter. State Street Corp grew its position in shares of CVS Health by 1.4% during the 2nd quarter. State Street Corp now owns 58,788,585 shares of the pharmacy operator’s stock valued at $4,055,237,000 after acquiring an additional 800,414 shares during the period. Geode Capital Management LLC increased its stake in shares of CVS Health by 2.4% in the 2nd quarter. Geode Capital Management LLC now owns 28,635,233 shares of the pharmacy operator’s stock worth $1,966,083,000 after purchasing an additional 675,824 shares in the last quarter. Invesco Ltd. raised its holdings in CVS Health by 15.3% in the 2nd quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock worth $1,623,270,000 after purchasing an additional 3,118,626 shares during the period. Finally, Norges Bank bought a new position in CVS Health in the 2nd quarter worth $1,358,698,000. Institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have commented on CVS. TD Cowen upped their price target on CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, December 10th. Sanford C. Bernstein reiterated a “market perform” rating and set a $91.00 price objective on shares of CVS Health in a research note on Tuesday, January 6th. Evercore ISI increased their target price on shares of CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Wells Fargo & Company lowered their price target on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a report on Thursday, November 13th. Finally, Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. Nineteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and an average target price of $94.82.

CVS Health Trading Up 1.8%

CVS stock opened at $76.80 on Wednesday. The company has a market capitalization of $97.49 billion, a price-to-earnings ratio of 202.11, a PEG ratio of 0.69 and a beta of 0.50. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. CVS Health Corporation has a 1-year low of $53.36 and a 1-year high of $85.15. The business has a 50 day simple moving average of $78.82 and a two-hundred day simple moving average of $75.43.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.5%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.